Circulating tumor cells (CTCs) are a population of tumor-derived cells that detach from the primary tumor and initiate metastasis. However, the mechanisms of this process are still unknown. This phenomenon renders CTCs as a valuable resource for prognosis and diagnosis of cancer. The involvement of stemness transcription factors and markers, such as NANOG, OCT3/4, CD34, NESTIN, and SOX2, in metastasis initiation has been studied recently because their abnormally elevated expression in cancer cells may be highly important in understanding tumor initiation. This study analyzed the genetic profiles of the above genes in CTCs derived from patients with different types of cancer. Blood samples were randomly collected from 71 cancer patients with various cancer types. CTCs were isolated using enrichment protocols and RNA was extracted. RT-qPCR was performed in triplicate using ACTB as the reference gene. The statistical analysis was performed among the ΔCts of the samples using parametric and non-parametric methods. The molecular analysis revealed that the expression of each gene was different than the others. When each type of cancer was analyzed separately, the gene expression profile was not always the same. It is noteworthy that, in all cases, the gene expression of NESTIN differed from that of transcription factors. According to the above data, gene expression profiles might be used as a potential biomarker or constitute a gene signature.
KeywordsStemnessCirculating Tumor CellsRT-qPCR
Ashworth, T.R. (1869) A Case of Cancer in Which Cells Similar to Those in the Tumors Were Seen in the Blood after Death. Australasian Medical Journal, 14, 146-149.
Allan, A.L. and Keeney, M. (2010) Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic. Journal of Oncology, 2010, Article ID: 426218. https://doi.org/10.1155/2010/426218
Wu, X.Z. (2008) Origin of Cancer Stem Cells: The Role of Self-Renewal and Differentiation. Annals of Surgical Oncology, 15, 407-414. https://doi.org/10.1245/s10434-007-9695-y
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.H., Diebel, M.E., Monville, F., Dutcher, J., et al. (2009) Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature. Cancer Research, 69, 1302-1313. https://doi.org/10.1158/0008-5472.CAN-08-2741
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007) Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science, 318, 1917-1920. https://doi.org/10.1126/science.1151526
Schoenhals, M., Kassambara, A., De Vos, J., Hose, D., Moreaux, J. and Klein, B. (2009) Embryonic Stem Cell Markers Expression in Cancers. Biochemical and Biophysical Research Communications, 383, 157-162. https://doi.org/10.1016/j.bbrc.2009.02.156
Jeter, C.R., Yang, T., Wang, J., Chao, H.P. and Tang, D.G. (2015) Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells, 33, 2381-2390. https://doi.org/10.1002/stem.2007
Neradil, J. and Veselska, R. (2015) Nestin as a Marker of Cancer Stem Cells. Cancer Science, 106, 803-811. https://doi.org/10.1111/cas.12691
Sidney, L.E., Branch, M.J., Dunphy, S.E., Dua, H.S. and Hopkinson, A. (2014) Concise Review: Evidence for CD34 as a Common Marker for Diverse Progenitors. Stem Cells, 32, 1380-1389. https://doi.org/10.1002/stem.1661
Pardal, R., Clarke, M.F. and Morrison, S.J. (2003) Applying the Principles of Stem-Cell Biology to Cancer. Nature Reviews Cancer, 3, 895-902. https://doi.org/10.1038/nrc1232
Ksiazkiewicz, M., Markiewicz, A. and Zaczek, A.J. (2012) Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer stem Cells. Pathobiology, 79, 195-208. https://doi.org/10.1159/000337106
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and Smith, A. (2003) Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells. Cell, 113, 643-655. https://doi.org/10.1016/S0092-8674(03)00392-1
Hay, D.C., Sutherland, L., Clark, J. and Burdon, T. (2004) Oct-4 Knockdown Induces Similar Patterns of Endoderm and Trophoblast Differentiation Markers in Human and Mouse Embryonic Stem Cells. Stem Cells, 22, 225-235. https://doi.org/10.1634/stemcells.22-2-225
Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N. and Lovell-Badge, R. (2003) Multipotent Cell Lineages in Early Mouse Development Depend on SOX2 Function. Genes & Development, 17, 126-140. https://doi.org/10.1101/gad.224503
Iv Santaliz-Ruiz, L.E., Xie, X., Old, M., Teknos, T.N. and Pan, Q. (2014) Emerging Role of Nanog in Tumorigenesis and Cancer Stem Cells. International Journal of Cancer, 135, 2741-2748. https://doi.org/10.1002/ijc.28690
Zeineddine, D., Hammoud, A.A., Mortada, M. and Boeuf, H. (2014) The Oct4 Protein: More Than a Magic Stemness Marker. American Journal of Stem Cells, 3, 74-82.
Kumar, S.M., Liu, S., Lu, H., Zhang, H., Zhang, P.J., Gimotty, P.A., Guerra, M., Guo, W. and Xu, X. (2012) Acquired Cancer Stem Cell Phenotypes through Oct4-Mediated Dedifferentiation. Oncogene, 31, 4898-4911. https://doi.org/10.1038/onc.2011.656
Jiang, W.L., Zhang, P.F., Li, G.F., Dong, J.H., Wang, X.S. and Wang, Y.Y. (2016) Oct-4 Is Associated with Gastric Cancer Progression and Prognosis. OncoTargets and Therapy, 9, 517-522.
Zhang, X., Han, B., Huang, J., Zheng, B., Geng, Q., Aziz, F. and Dong, Q. (2010) Prognostic Significance of OCT4 Expression in Adenocarcinoma of the Lung. Japanese Journal of Clinical Oncology, 40, 961-966. https://doi.org/10.1093/jjco/hyq066
Hu, L., McArthur, C. and Jaffe, R.B. (2010) Ovarian Cancer Stem-Like Side-Population Cells Are Tumourigenic and Chemoresistant. British Journal of Cancer, 102, 1276-1283. https://doi.org/10.1038/sj.bjc.6605626
Peng, S., Maihle, N.J. and Huang, Y. (2010) Pluripotency Factors Lin28 and Oct4 Identify a Sub-Population of Stem Cell-Like Cells in Ovarian Cancer. Oncogene, 29, 2153-2159. https://doi.org/10.1038/onc.2009.500
Liu, T., Xu, F., Du, X., Lai, D., Zhao, Y., Huang, Q., Jiang, L., Huang, W., Cheng, W. and Liu, Z. (2010) Establishment and Characterization of Multi-Drug Resistant, Prostate Carcinoma-Initiating Stem-Like Cells from Human Prostate Cancer Cell Lines 22RV1. Molecular and Cellular Biochemistry, 340, 265-273. https://doi.org/10.1007/s11010-010-0426-5
Saigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Ioue, Y., Miki, C. and Kusunoki, M. (2009) Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence after Chemoradiotherapy. Annals of Surgical Oncology, 16, 3488-3498. https://doi.org/10.1245/s10434-009-0617-z
Pan, G. and Thomson, J.A. (2007) Nanog and Transcriptional Networks in Embryonic Stem Cell Pluripotency. Cell Research, 17, 42-49. https://doi.org/10.1038/sj.cr.7310125
Wang, M.L., Chiou, S.H. and Wu, C.W. (2013) Targeting Cancer Stem Cells: Emerging Role of Nanog Transcription Factor. OncoTargets and Therapy, 6, 1207-1220.
Han, J., Zhang, F., Yu, M., Zhao, P., Ji, W., Zhang, H., Wu, B., Wang, Y. and Niu, R. (2012) RNA Interference-Mediated Silencing of NANOG Reduces Cell Proliferation and Induces G0/G1 Cell Cycle Arrest in Breast Cancer Cells. Cancer Letters, 321, 80-88. https://doi.org/10.1016/j.canlet.2012.02.021
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., et al. (2005) Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells. Cell, 122, 947-956. https://doi.org/10.1016/j.cell.2005.08.020
Weina, K. and Utikal, J. (2014) SOX2 and Cancer: Current Research and Its Implications in the Clinic. Clinical and Translational Medicine, 3, 19. https://doi.org/10.1186/2001-1326-3-19
Foster, R., Buckanovich, R.J. and Rueda, B.R. (2013) Ovarian Cancer Stem Cells: Working towards the Root of Stemness. Cancer Letters, 338, 147-157. https://doi.org/10.1016/j.canlet.2012.10.023
Michalczyk, K. and Ziman, M. (2005) Nestin Structure and Predicted Function in Cellular Cytoskeletal Organisation. Histology and Histopathology, 20, 665-671.
Barriere, G., Fici, P., Gallerani, G., Fabbri, F., Zoli, W. and Rigaud, M. (2014) Circulating Tumor Cells and Epithelial, Mesenchymal and Stemness Markers: Characterization of Cell Subpopulations. Annals of Translational Medicine, 2, 109.
Barriere, G., Riouallon, A., Renaudie, J., Tartary, M. and Rigaud, M. (2012) Mesenchymal and Stemness Circulating Tumor Cells in Early Breast Cancer Diagnosis. BMC Cancer, 12, 114. https://doi.org/10.1186/1471-2407-12-114
Grillet, F., Bayet, E., Villeronce, O., Zappia, L., Lagerqvist, E.L., Lunke, S., Charafe-Jauffret, E., Pham, K., Molck, C., Rolland, N., et al. (2016) Circulating Tumour Cells from Patients with Colorectal Cancer Have Cancer Stem Cell Hallmarks in Ex Vivo Culture. Gut, 1-9.
Blassl, C., Kuhlmann, J.D., Webers, A., Wimberger, P., Fehm, T. and Neubauer, H. (2016) Gene Expression Profiling of Single Circulating Tumor Cells in Ovarian Cancer—Establishment of a Multi-Marker Gene Panel. Molecular Oncology, 10, 1030-1042. https://doi.org/10.1016/j.molonc.2016.04.002
Livak, K.J. and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408. https://doi.org/10.1006/meth.2001.1262
Hammer, O., Harper, D.A.T. and Ryan, P.D. (2001) PAST: Paleontological Statistics Software Package for Education and Data Analysis. Paleontologica Electronica, 4, 9.